Uncategorised - European Medical Journal

High Pacemaker Implantation Rates After Transcatheter Aortic Valve Implantation

Rates of permanent pacemaker implantation exceed 20% in patients with aortic regurgitation.

Urine Tumour DNA Could Guide Therapeutic Decisions in Bladder Cancer

Profiling urine tumour DNA at baseline and after 3 months of treatment could identify whether patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer might not benefit from systemic immunotherapy.

Chronic Inflammation Linked to Increased Affective Disorders

Chronic exposure to systemic inflammation may be associated to a greater risk of affective disorders.

Can Post-Treatment MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy?

Pathologic complete response was accurately predicted by post-treatment MRI in patients with early triple-negative breast cancer having undergone neoadjuvant chemoimmunotherapy.

Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Pharma seized the spotlight at Cannes Lions – here's why

In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.

Hyperbaric Oxygen Therapy Leads Diabetic Foot Ulcer Treatment Rankings in New Meta-Analysis

Hyperbaric oxygen therapy ranks highest for healing diabetic foot ulcers but may raise amputation risk, new network meta-analysis reveals.

Study Links Bifidobacterium Deficit in Infants in the USA to Gut Dysbiosis

One in four U.S. infants lacks Bifidobacterium, a key gut microbe essential for immune and metabolic health.

Deucravacitinib Therapy in Plaque Psoriasis

Psoriasis is a common, chronic, inflammatory skin disease characterized by accelerated epidermal proliferation. The most common subtype is…

Silent Sexual Health Crisis After Breast Cancer

Sexual health problems are highly prevalent and distressing among breast cancer survivors, yet the majority of women report receiving little to no support from their healthcare teams, according to findings from the WISH-BREAST survey.